Latest News

Date Title Topic
08 Nov 2017 FDA Approves Alectinib for ALK Positive Metastatic NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
06 Nov 2017 ESMO Media Alert: ESMO Asia 2017 Congress
06 Nov 2017 Distinct Cancer Profiles Described Among Young Adults Aged 20 to 39 Years Epidemiology/Etiology/Cancer Prevention
03 Nov 2017 FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Nov 2017 ESMO Media Alert: Cancer Research to be Presented at ESMO Asia Congress in Singapore
02 Nov 2017 Predictive Model May Determine Risk of Subsequent CNS Tumour in Survivors of Childhood Cancer Central nervous system malignancies - Translational research - Cancer in Special Situations
02 Nov 2017 Patient Guide in NSCLC Now Available in Italian
01 Nov 2017 ESMO Media Alert: It is Time for a Concerted European Approach to Defeat Cancer
30 Oct 2017 Rolapitant i.v. Approved by FDA for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy Palliative and supportive care
Travel Grants
27 Oct 2017 NICE Announce Nivolumab To Be Available for Some Patients with Head and Neck Cancer Head and neck cancers - Cancer Immunology and Immunotherapy
26 Oct 2017 ASTRO 2017: External Beam Radiotherapy Plus Two Different Fractionation Schedules of High-Dose Rate Brachytherapy for Cervical Cancer Gynaecologic malignancies
25 Oct 2017 ASTRO 2017: Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin in Patients with High-Risk, Early-Stage Endometrial Cancer Gynaecologic malignancies
24 Oct 2017 IASLC WCLC 2017: Patient-Reported Outcomes in the PACIFIC Study Lung and other thoracic tumours - Cancer Immunology and Immunotherapy